Green Cross Corp

006280

Company Profile

  • Business description

    Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

  • Contact

    303 Bojeong-Dong
    Giheung-Gu
    YonginGyeonggi449-070
    KOR

    T: +82 312609300

    http://www.greencross.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,276

Stocks News & Analysis

stocks

10 of the cheapest global companies with wide moats

These undervalued stocks of high-quality companies could be attractive investments today.
stocks

Bookworm: Buy and hold inspiration from an unlikely source

Ben Graham was the king of flipping deep value stocks. The best investment of his life came from something very different.
stocks

3 ASX shares to avoid

These shares have surged in price in the last year but are significantly overvalued according to our analysts. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,082.1068.800.86%
CAC 408,050.6022.320.28%
DAX 4023,019.1832.360.14%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,647.7515.420.18%
HKSE24,145.57185.590.77%
NASDAQ17,754.09451.072.61%
Nikkei 22537,396.52343.420.93%
NZX 50 Index12,166.14100.11-0.82%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,854.1064.400.83%
SSE Composite Index3,426.136.570.19%

Market Movers